Bases moleculares y celulares de enfermedades inflamatorias/autoinmunes
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (11)
2023
-
Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs
Rheumatology and Therapy, Vol. 10, Núm. 2, pp. 357-373
2021
-
Pregnancy Control in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Part 1: Infertility, Ovarian Preservation and Preconception Assessment. Consensus Document of the Spanish Society of Gynaecology and Obstetrics (SEGO), the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Rheumatology (SER)
Reumatologia Clinica, Vol. 17, Núm. 2, pp. 61-66
-
Pregnancy control in Patients with Systemic Lupus Erythematosus/Antiphospholipid Syndrome. Part 3: Childbirth. Puerperium. Breastfeeding Contraception. Newborn
Reumatologia Clinica, Vol. 17, Núm. 4, pp. 183-186
-
Pregnancy control in patients with systemic lupus erythematosus/antiphospholipid syndrome. Part 2: Pregnancy follow-up
Reumatologia Clinica, Vol. 17, Núm. 3, pp. 125-131
2020
-
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies
Autoimmunity Reviews, Vol. 19, Núm. 1
-
Recommendations of the Spanish Rheumatology Society for Primary Antiphospholipid Syndrome. Part I: Diagnosis, Evaluation and Treatment
Reumatologia Clinica, Vol. 16, Núm. 2P1, pp. 71-86
2015
2011
-
Synovial fibroblast hyperplasia in rheumatoid arthritis: Clinicopathologic correlations and partial reversal by anti-tumor necrosis factor therapy
Arthritis and Rheumatism, Vol. 63, Núm. 9, pp. 2575-2583
2009
-
Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor α therapy in rheumatoid arthritis
Annals of the Rheumatic Diseases, Vol. 68, Núm. 5, pp. 751-756
2008
-
Immunotherapy for neurological diseases
Clinical Immunology
2004
-
Antiangiogenic Effects of Anti-Tumor Necrosis Factor α Therapy with Infliximab in Psoriatic Arthritis
Arthritis and Rheumatism, Vol. 50, Núm. 5, pp. 1636-1641